| abstract |
The present invention generally relates to antibodies that bind to CD3, including, for example, multispecific antibodies for activating T cells. Furthermore, the present invention relates to polynucleotides encoding such antibodies as well as vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing said antibodies and methods of using said antibodies in the treatment of diseases. |